How To Use CPT Code 0660T

CPT 0660T describes the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system using an internal approach. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0660T?

CPT 0660T can be used to describe the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system. This procedure involves inserting an implant into the eye that delivers a drug at a controlled rate into the front-most region of the eye, known as the anterior segment. The purpose of this procedure is to treat conditions such as glaucoma.

2. Official Description

The official description of CPT code 0660T is: ‘Implantation of anterior segment intraocular nonbiodegradable drug-eluting system, internal approach (Report medication separately).’ This code specifically refers to the implantation of a drug-eluting system into the anterior segment of the eye using an internal approach.

3. Procedure

1. The provider prepares the patient and administers anesthesia.
2. A small incision is made, and the provider examines the anterior chamber angle using an ab interno approach.
3. The provider implants the drug-eluting system, which may include an anchor, a drug reservoir, and a membrane for controlled release of the drug.
4. The provider removes the tools used for implantation and completes the procedure.

4. Qualifying circumstances

CPT 0660T is performed on patients who require the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system. This procedure is typically used to treat conditions such as glaucoma, which is characterized by increased intraocular pressure. The provider must use an internal approach to access the anterior chamber angle and implant the drug-eluting system.

5. When to use CPT code 0660T

CPT code 0660T should be used when the provider performs the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system using an internal approach. This code is specific to this procedure and should not be used for other types of eye surgeries or interventions.

6. Documentation requirements

To support a claim for CPT 0660T, the provider must document the following information:

• Patient’s diagnosis and the need for the implantation of the drug-eluting system
• Description of the drug-eluting system used, including any specific components
• Date and details of the procedure, including the approach used
• Any additional medications administered during the procedure
• Any complications or adverse events that occurred
• Signature of the provider performing the procedure

7. Billing guidelines

When billing for CPT 0660T, ensure that the procedure meets the specific criteria outlined in the code description. The drug used in the procedure should be reported separately. It is important to follow any additional guidelines provided by payers or coding authorities. For removal and reimplantation of the drug-eluting system, refer to CPT code 0661T. Consider the location of the testing when coding these procedures, as they may have both a professional and technical component.

8. Historical information

CPT 0660T was added to the Current Procedural Terminology system on July 1, 2021. As a relatively new code, there have been no updates or changes since its addition.

9. Examples

1. A provider implants an anterior segment intraocular nonbiodegradable drug-eluting system to treat glaucoma in a patient.
2. Using an internal approach, a provider inserts a drug-eluting system into the anterior segment of the eye to manage intraocular pressure in a patient with glaucoma.
3. A patient undergoes the implantation of a drug-eluting system into the anterior chamber angle to treat their glaucoma.
4. A provider performs the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system using an internal approach to deliver medication for a patient with glaucoma.
5. Using an ab interno approach, a provider inserts a drug-eluting system into the anterior segment of the eye to treat a patient’s glaucoma.
6. A patient with glaucoma undergoes the implantation of a drug-eluting system into the anterior chamber angle using an internal approach.
7. A provider performs the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system to manage intraocular pressure in a patient with glaucoma.
8. Using an internal approach, a provider inserts a drug-eluting system into the anterior segment of the eye to treat a patient’s glaucoma.
9. A patient receives the implantation of a drug-eluting system into the anterior chamber angle to manage their glaucoma.
10. A provider performs the implantation of an anterior segment intraocular nonbiodegradable drug-eluting system using an internal approach to deliver medication for a patient with glaucoma.